Sanofi – Aventis will enter the Chinese OTC market – Sanofi – Aventis – Pharmaceutical industries
Sanofi – Aventis (Euronext code: SAN, NYSE: SNY) 10 dated 24 Hangzhou Minsheng Pharmaceutical Co., Ltd. signed a letter of intent, expressed willingness to jointly form a new joint venture, consumer health care products .
To be formally Cooperation Agreement was signed, Sanofi – Aventis joint venture to be in the majority of the shares. West Lake International Expo in 2009, the two sides signed the Letter of Intent on, Hangzhou principal leaders attended and witnessed the signing ceremony.
Sanofi – Aventis Pharma, a joint venture with the people's livelihood will be the main production and management Vitamin And mineral products. Vitamin and mineral products is the largest OTC market in a category, people's livelihood and medicine, with its flagship brand VITA 21 Gold ®, has been in the field has considerable strength. The new joint venture will become Sanofi – Aventis OTC market into China's strategic platform. Sanofi – Aventis is the world's sixth largest non-prescription drug business and continued through mergers and acquisitions, expand its global consumer health care field strength. September 2008, Sanofi – Aventis announced the completion of the acquisition of the SymbionConsumer, the company is a leading health care in Australia and New Zealand Food And non-prescription drug business.
Sanofi – Aventis Group, Asia Pacific, Russia and Japan senior vice president Xia Liwei (OlivierCharmeil) said: "China will become the world's second largest 2010 non-prescription drug market. The proposed joint venture is a consumer health care products match Nuofei – Aventis OTC market into China's strategic initiatives. Group is China's prescription drugs and vaccines leader in the field of brewing in the joint venture will further strengthen Sanofi – Aventis the strength of China, confirms the Group of China commitment. to have the opportunity to explore new cooperation livelihood medicine, we are particularly excited. Sanofi – Aventis China's giant strides in the development and successful history of medicine is inseparable from our people's livelihood in the area of prescription drugs fruitful cooperation. "
Hangzhou Minsheng Pharmaceutical Co., Ltd. Chairman Zhu Fujiang said: "We and Sanofi – Aventis has 10 years of happy collaboration of history, and now the new consumer medical products on the cooperation of the project is exciting event. sanofi – aventis is a very dynamic and vitality of the enterprise, the success of prescription drugs and vaccines have been amply demonstrated its Marketing Ability, we hope that the new projects of cooperation, make the people's livelihood medicine vitamin products to cover all markets, so that more people enjoy health protection, but also hope the project platform, can develop more and all health products, contribute to local economic development, while consumers can bring more and better health protection services. "
2008, China's OTC market size of about 70 billion euros (about 70 billion yuan), and is expected to maintain double-digit growth the next five years, including positive factors include: the ability of consumers to pay increased gradually; government increasingly focused on health awareness and disease prevention, to further promote the self-care; and pharmacy chains and the rapid development of modern commerce.
I am a professional editor from Chinese Manufacturers,
and my work is to promote a free online trade platform.
http://www.chinaqualitycrafts.com/ contain a great deal of information about
3db hybrid coupler , cellular phone repeaters
welcome to visit!
Processing your request, Please wait....
